kenneth o byrne

kenneth o byrne

Queensland University of Technology - Brisbane / Australia
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 125300
person_outline kenneth o byrne's MOST POPULAR ARTICLES
1-) Pembrolizumab versus chemotherapy for PD-L1–positive non–small-cell lung cancer New England Journal of Medicine 375 (19), 1823-1833, 2016
2-) Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer New England journal of medicine 378 (2), 113-125, 2018
3-) Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer New England Journal of Medicine 377 (20), 1919-1929, 2017
4-) Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer New England Journal of Medicine 368 (25), 2385-2394, 2013
5-) Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations Journal of clinical oncology 31 (27), 3327-3334, 2013